A Phase 1, Open-Label Study to Assess the Metabolism, Excretion, and Mass Balance of [14C]-Plazomicin Following a Single IV Infusion in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Oct 2018
Price : $35 *
At a glance
- Drugs Plazomicin (Primary)
- Indications Bacteraemia; Gram-negative infections; Nosocomial pneumonia; Pyelonephritis; Urinary tract infections
- Focus Pharmacokinetics
- Sponsors Achaogen
- 07 Oct 2018 Results assessing pharmacokinetic parameters of plazomicin in Healthy subjects, presented at the IDWeek 2018.
- 11 Jul 2017 Status changed from active, no longer recruiting to completed.
- 07 Jul 2017 Planned End Date changed from 30 Jun 2017 to 10 Jul 2017.